Supernus Pharmaceuticals reported $31.24M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2469M 317M
Ani Pharmaceuticals ANIP:US $ 11.04M 5.43M
Antares Pharma ATRS:US $ 5.56M 1.18M
Aphria Inc APH:CN C$ -353810000 214.73M
Aurora Cannabis Inc ACB:CN -164779000 107.07M
Canopy Growth Corp WEED:CN C$ 392.85M 1B
Cara Therapeutics CARA:US $ -30745000 7.44M
Eisai 4523:JP Y 55783M 61588M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Endo International Ordinary Shares ENDP:US $ 181.61M 22.56M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Supernus Pharmaceuticals SUPN:US $ 31.24M 20.31M
United Therapeutics UTHR:US $ 216.5M 184M